James Hamilton
Patrimonio netto: 19 M $ in data 30/06/2026
Patrimonio netto: 19 M $ in data 30/06/2026
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. Dr. Hamilton is Chief Medical Officer, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Hamilton was Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton completed undergraduate studies at Miami University and earned an MBA and a doctorate from The Ohio State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/03/2026 | 236.958 ( 0,17% ) | 19 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2025 |
| Società | Posizione | Fine |
|---|---|---|
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Fondatore | - |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale